Kintara Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch KTRA and buy or sell other stocks, ETFs, and their options commission-free!About KTRA
TuHURA Biosciences, Inc. is a clinical-stage immuno-oncology company, which engages in the development of novel technologies to overcome resistance to cancer immunotherapy. The firm’s lead product candidate, IFx2.0, is an innate immune agonist designed to overcome primary resistance to checkpoint inhibitors.
CEOJames A. Bianco, MD
CEOJames A. Bianco, MD
Employees19
Employees19
HeadquartersTampa, Florida
HeadquartersTampa, Florida
Founded
Founded
Employees19
Employees19
KTRA Key Statistics
Market cap5.40M
Market cap5.40M
Price-Earnings ratio-0.34
Price-Earnings ratio-0.34
Dividend yield—
Dividend yield—
Average volume98.35K
Average volume98.35K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$7.93
52 Week high$7.93
52 Week low$1.80
52 Week low$1.80
Stock Snapshot
As of today, Kintara Therapeutics(KTRA) shares are valued at $0.12. The company's market cap stands at 5.4M, with a P/E ratio of -0.34.
Kintara Therapeutics(KTRA) stock opened on 2025-12-06 at —. The price climbed to — and dipped to —.
Kintara Therapeutics(KTRA) shares are trading with a volume of 0, against a daily average of 98.35K.
In the last year, Kintara Therapeutics(KTRA) shares hit a 52-week high of $7.93 and a 52-week low of $1.80.
In the last year, Kintara Therapeutics(KTRA) shares hit a 52-week high of $7.93 and a 52-week low of $1.80.
People also own
Based on the portfolios of people who own KTRA. This list is generated using Robinhood data, and it’s not a recommendation.